Surrogacy in HIV-1 clinical trials

This publication has 12 references indexed in Scilit:

• A Critical Assessment of the Prognostic Value of HIV-1 RNA Levels and CD4+ Cell Counts in HIV-Infected Patients
  Archives of internal medicine (1960), 1998
• Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
  New England Journal of Medicine, 1997
• A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less
  New England Journal of Medicine, 1997
• An approach to the validation of markers for use in AIDS clinical trials.
  Clinical Infectious Diseases, 1997
• Perspective: Validating Surrogate Markers--Are We Being Naive?
  The Journal of Infectious Diseases, 1997
• The Relation of Virologic and Immunologic Markers to Clinical Outcomes after Nucleoside Therapy in HIV-Infected Adults with 200 to 500 CD4 Cells per Cubic Millimeter
  New England Journal of Medicine, 1996
• Surrogate End Points in Clinical Trials: Are We Being Misled?
  Annals of Internal Medicine, 1996
• Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma
  Science, 1996
• Changes in Plasma HIV-1 RNA and CD4+ Lymphocyte Counts and the Risk of Progression to AIDS
  New England Journal of Medicine, 1996
• Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or Placebo
  New England Journal of Medicine, 1991